VIVIAN DUONG: Open Payments
NPI 1235786062 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 47 payments from 7 companies in 2025. Trend: 2023 $1,105 · 2024 $1,198 · 2025 $790
Food & beverage: $790
| Company | Payments | Amount |
|---|---|---|
| SHIELD THERAPEUTICS INC | 33 | $420 |
| Astellas Pharma US Inc | 1 | $155 |
| Evofem Biosciences, Inc. | 6 | $72 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| Exeltis, USA Inc. | 2 | $32 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $31 |
| PFIZER INC. | 1 | $18 |
Products named: ACCRUFER, Veozah, Phexxi, MYFEMBREE, SLYND, ABRYSVO.
Industry payments across TX — which companies pay providers there.
